Yassaman Vafai1, Edwina H Yeung1, Rajeshwari Sundaram2, Melissa M Smarr3, Nicole Gerlanc4, William A Grobman5, Daniel Skupski6, Edward K Chien7,8, Stefanie N Hinkle1, Roger B Newman9, Deborah A Wing10,11, Angela C Ranzini12, Anthony Sciscione13, Jagteshwar Grewal1, Cuilin Zhang1, Katherine L Grantz1. 1. Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. 2. Biostatistics and Bioinformatics Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. 3. Population Health Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Durham, North Carolina. 4. Prospective Group Inc, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. 5. Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 6. New York Presbyterian Queens, Flushing, New York. 7. Women and Infants Hospital, Providence, Rhode Island. 8. Case Western Reserve University, MetroHealth Medical Center, Cleveland, Ohio. 9. Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina. 10. University of California, Irvine, Orange, California. 11. Fountain Valley Regional Hospital and Medical Center, Fountain Valley, California. 12. Saint Peter's University Hospital, New Brunswick, New Jersey. 13. Department of Obstetrics and Gynecology, Christiana Care Health System, Wilmington, Delaware.
Abstract
OBJECTIVE: This study aimed to describe the overall quantity and type of supplements and medications used during pregnancy in a low-risk cohort and to examine any racial/ethnic differences in intake. STUDY DESIGN: We used data from 2,164 racially/ethnically diverse, nonobese, and low-risk pregnant women participating without pre-pregnancy chronic conditions in a prospective cohort study at 12 sites across the United States. Medication data were self-reported as free text in enrollment, follow-up visit questionnaires, and abstracted from medical records at delivery. Supplements and medications data were mapped to their active ingredients and categorized into corresponding classes using the Slone Drug Dictionary. The total number and classes of supplements and medications consumed during pregnancy were calculated. Modified Poisson regression models were used to estimate the racial/ethnic differences in supplements and medications intake. All models were adjusted for maternal sociodemographic factors and study site. RESULTS: 98% of women took at least one supplement during pregnancy, with prenatal vitamins/multivitamins being most common. While only 31% reported taking no medications during pregnancy, 23% took one, 18% took two, and 28% took three or more. The percentage of women taking at least one medication during pregnancy was highest among non-Hispanic white women and lowest among Asians (84 vs. 55%, p < 0.001). All racial/ethnic groups reported taking the same top four medication classes including central nervous system agents, gastrointestinal drugs, anti-infective agents, and antihistamines. Compared with non-Hispanic white women, Hispanic (adjusted relative risk [aRR]: 0.84, 95% confidence interval [CI]: 0.71-0.98), and Asian women (aRR: 0.83, 95% CI: 0.70-0.98) were less likely to take central nervous system agents, as well as gastrointestinal drugs (Hispanics aRR: 0.79, 95% CI: 0.66-0.94; Asians aRR = 0.75, 95% CI: 0.63-0.90), and antihistamines (Hispanics aRR: 0.65, 95% CI: 0.47-0.92). CONCLUSION: Supplement intake was nearly universal. Medication use was also common among this low-risk pregnancy cohort and differed by race/ethnicity. GOV IDENTIFIER: NCT00912132. KEY POINTS: · In women without chronic conditions, medication use is common.. · Racial/ethnic differences exist in prenatal medications use.. · Almost all women use supplements during pregnancy.. Thieme. All rights reserved.
OBJECTIVE: This study aimed to describe the overall quantity and type of supplements and medications used during pregnancy in a low-risk cohort and to examine any racial/ethnic differences in intake. STUDY DESIGN: We used data from 2,164 racially/ethnically diverse, nonobese, and low-risk pregnant women participating without pre-pregnancy chronic conditions in a prospective cohort study at 12 sites across the United States. Medication data were self-reported as free text in enrollment, follow-up visit questionnaires, and abstracted from medical records at delivery. Supplements and medications data were mapped to their active ingredients and categorized into corresponding classes using the Slone Drug Dictionary. The total number and classes of supplements and medications consumed during pregnancy were calculated. Modified Poisson regression models were used to estimate the racial/ethnic differences in supplements and medications intake. All models were adjusted for maternal sociodemographic factors and study site. RESULTS: 98% of women took at least one supplement during pregnancy, with prenatal vitamins/multivitamins being most common. While only 31% reported taking no medications during pregnancy, 23% took one, 18% took two, and 28% took three or more. The percentage of women taking at least one medication during pregnancy was highest among non-Hispanic white women and lowest among Asians (84 vs. 55%, p < 0.001). All racial/ethnic groups reported taking the same top four medication classes including central nervous system agents, gastrointestinal drugs, anti-infective agents, and antihistamines. Compared with non-Hispanic white women, Hispanic (adjusted relative risk [aRR]: 0.84, 95% confidence interval [CI]: 0.71-0.98), and Asian women (aRR: 0.83, 95% CI: 0.70-0.98) were less likely to take central nervous system agents, as well as gastrointestinal drugs (Hispanics aRR: 0.79, 95% CI: 0.66-0.94; Asians aRR = 0.75, 95% CI: 0.63-0.90), and antihistamines (Hispanics aRR: 0.65, 95% CI: 0.47-0.92). CONCLUSION: Supplement intake was nearly universal. Medication use was also common among this low-risk pregnancy cohort and differed by race/ethnicity. GOV IDENTIFIER: NCT00912132. KEY POINTS: · In women without chronic conditions, medication use is common.. · Racial/ethnic differences exist in prenatal medications use.. · Almost all women use supplements during pregnancy.. Thieme. All rights reserved.
Authors: Erika Hyde Riley; Elena Fuentes-Afflick; Rebecca A Jackson; Gabriel J Escobar; Phyllis Brawarsky; Meighan Schreiber; Jennifer S Haas Journal: J Womens Health (Larchmt) Date: 2005-06 Impact factor: 2.681
Authors: Molly M Lynch; Linda B Squiers; Katherine M Kosa; Suzanne Dolina; Jennifer Gard Read; Cheryl S Broussard; Meghan T Frey; Kara N Polen; Jennifer N Lind; Suzanne M Gilboa; Janis Biermann Journal: Matern Child Health J Date: 2018-01
Authors: David M Haas; Derek J Marsh; Danny T Dang; Corette B Parker; Deborah A Wing; Hyagriv N Simhan; William A Grobman; Brian M Mercer; Robert M Silver; Matthew K Hoffman; Samuel Parry; Jay D Iams; Steve N Caritis; Ronald J Wapner; M Sean Esplin; Michal A Elovitz; Alan M Peaceman; Judith Chung; George R Saade; Uma M Reddy Journal: Obstet Gynecol Date: 2018-05 Impact factor: 7.661
Authors: A Lupattelli; O Spigset; M J Twigg; K Zagorodnikova; A C Mårdby; M E Moretti; M Drozd; A Panchaud; K Hämeen-Anttila; A Rieutord; R Gjergja Juraski; M Odalovic; D Kennedy; G Rudolf; H Juch; A Passier; I Björnsdóttir; H Nordeng Journal: BMJ Open Date: 2014-02-17 Impact factor: 2.692
Authors: Cheryl Robbins; Sheree L Boulet; Isabel Morgan; Denise V D'Angelo; Lauren B Zapata; Brian Morrow; Andrea Sharma; Charlan D Kroelinger Journal: MMWR Surveill Summ Date: 2018-01-19
Authors: Yassaman Vafai; Edwina H Yeung; Rajeshwari Sundaram; Melissa M Smarr; Nicole Gerlanc; William A Grobman; Daniel Skupski; Edward K Chien; Stefanie N Hinkle; Roger B Newman; Deborah A Wing; Angela C Ranzini; Anthony Sciscione; Jagteshwar Grewal; Cuilin Zhang; Katherine L Grantz Journal: J Matern Fetal Neonatal Med Date: 2021-03-11